BDBM516582 (2R)-2-(diethylamino)-1- [(2S)-2-(5-{4-[5-(2-{(2S)- 1-[(2R)-2-(diethylamino)- 2-phenylacetyl]pyrrolidin- 2-yl}-1H-imidazol-5-yl)-1- benzofuran-2-yl]phenyl}- 1H-imidazol-2-yl) pyrrolidin-1-yl]-2- phenylethanone::US11053243, Example 193

SMILES CCN(CC)[C@@H](C(=O)N1CCC[C@H]1c1ncc([nH]1)-c1ccc(cc1)-c1cc2cc(ccc2o1)-c1cnc([nH]1)[C@@H]1CCCN1C(=O)[C@H](N(CC)CC)c1ccccc1)c1ccccc1

InChI Key

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 516582   

TargetGenome polyprotein(Hepatitis C Virus (Virus))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM516582((2R)-2-(diethylamino)-1- [(2S)-2-(5-{4-[5-(2-{(2S)...)
Affinity DataEC50:  0.0500nMAssay Description:Measurement of inhibition by compounds was performed using the HCV replicon system. Several different replicons encoding different HCV genotypes or m...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent